Florida Launched Statewide Newborn Genomic Screening

The five-year pilot program targets early identification of nearly 900 rare genetic conditions in newborns.

Updated on Oct. 5, 2026 in Life Sciences

Isometric editorial illustration of a geometric DNA double helix structure, representing statewide genomic screening programs.
Florida has launched the Sunshine Genetics Pilot Program, a five-year initiative providing free whole genome sequencing to newborns to identify nearly 900 rare genetic conditions. AI Illustration. Upload story photo >

Live Poll

Do you support state-funded universal genomic screening programs for all newborns?

Florida has initiated the Sunshine Genetics Pilot Program, which provides free, voluntary newborn whole genome sequencing. Baylor Genetics serves as the lead sequencing partner for this five-year state initiative.

Why it matters

The Sunshine Genetics Act aims to improve clinical outcomes by identifying rare, actionable genetic conditions shortly after birth. This program represents a state-level expansion of large-scale genomic screening for pediatric populations.

The initiative utilizes whole genome sequencing to screen for 900 distinct genetic conditions over a five-year period. Baylor Genetics processes these clinical sequences as the primary diagnostic partner for the state program.

The players

Baylor Genetics

A diagnostic laboratory headquartered in Houston that specializes in clinical whole genome sequencing and rare disease identification.

Florida Institute for Pediatric Rare Diseases

A research and administrative body based at Florida State University focused on the detection and management of rare genetic disorders.

Pediatrica Health Group

A network of pediatric clinics facilitating the initial enrollment phase for statewide genetic screening.

The details

Parents and legal guardians may enroll newborns at participating Pediatrica Health Group sites for whole genome sequencing—the process of determining the entirety of an organism's DNA code. The Florida Institute for Pediatric Rare Diseases at Florida State University administers the program, which analyzes the data to identify markers associated with nearly 900 rare conditions. Baylor Genetics, based in Houston, acts as the primary laboratory facility responsible for the diagnostic sequencing.

Timeline

  1. October 5, 2026: The Sunshine Genetics Pilot Program began enrollment with Baylor Genetics as the lead partner.

The Tech Race

This program reflects the broader trend of states integrating large-scale genomic sequencing into standard newborn public health efforts. It follows the establishment of the Sunshine Genetics Act, setting a state-level precedent for genomic health data integration.

Eligible residents can access voluntary, free genomic screening for their newborns through designated Pediatrica Health Group locations. The program is currently active and is scheduled to continue for a five-year duration.

The takeaway

The program shifts the paradigm from symptomatic testing to proactive genomic surveillance for newborns. Residents should monitor for future updates on screening expansion or data reporting intervals over the next five years.

Further reading

Learn more about the latest developments in genomic diagnostics in the Life Sciences section.

Live Poll

Do you support state-funded universal genomic screening programs for all newborns?